JUN 14, 2017 04:13 PM PDT

Identifying A Rare Autoimmune Disease at the Cellular Level

WRITTEN BY: Kara Marker

Diagnostic tests for a rare autoimmune disease called anti-phospholipid antibody syndrome (APS) are unreliable, and treatments are not sustainable long-term. However, a new discovery of the disease’s causation from the University of Geneva might alter solutions for both of these problems.

 Anti-phospholipid antibody syndrome occurs when the immune system attacks normal proteins in the blood.

APS is characterized by autoantibodies in the blood plasma that target anticoagulant proteins, leading to excessive blood clotting. Binding of these autoantibodies can occur in the blood vessels and in the placenta, with dangerous consequences such as venous thromboses, strokes, and miscarriages. APS is rare, affecting less than one percent of the population, but this condition often occurs simultaneously with lupus or rheumatoid arthritis.

Current diagnostic approaches for APS require the expertise of a hematologist, an extensive review of a patient’s medical history, and blood tests scanning for three antibodies that indicate APS: anticardiolipin, beta-2 glycoprotein I, lupus anticoagulant. However, variability, specificity, and sensitivity of these tests are not always dependable.

Treatment options for APS almost exclusively involve oral anticoagulants, but extended use raises risk of adverse side effects, especially for pregnant women.

"The current diagnostic tests use the entire protein, which reduces its specificity and leads to standardization issues,” explained Karim Brandt, a researcher from the study. “Consequently, two tests are required at an interval of 12 weeks after a thrombotic episode or following one or more miscarriages. Our new test specifically targets this pathogenic antibody, with rapid and more accurate results."

The new diagnostic approach is to be devised based upon the discovery of the precise location of anti-phospholipid antibody binding. Identifying the exact location of binding allowed scientists to study in detail how the binding occurs and its specific effects on blood clotting. They found that binding triggers the release of pro-inflammatory and pro-thrombotic factors that are the basis of the condition’s dangerous consequences. 

"Our breakthrough could also give rise to a targeted treatment that would neutralize specific pathogenic antibodies, reducing not just their actions but also the side effects associated with the current treatment,” Brandt explained. “It would involve injecting the protein motif we have identified into a patient's circulatory system so that it explicitly binds itself to the pathogenic antibody and prevents it from causing harm."

The present study was published in the journal Haematologica.

Sources: National Heart, Lung, and Blood Institute, University of Geneva

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
MAY 07, 2018
Immunology
MAY 07, 2018
Breast Milk: An Important Source of Protective Immune Cells
For the first time, scientists have identified innate lymphoid cells (ILCs) among the arsenal of protective cells transferred to newborn babies via breast...
JUN 22, 2018
Health & Medicine
JUN 22, 2018
A New Test for Peanut Allergy: Better, Faster, Cheaper.
Scientists from the Medical Research Council (MRC) in the UK have come up with a test to detect peanut allergies and it’s safer, quicker and more acc...
AUG 13, 2018
Immunology
AUG 13, 2018
Silent Viruses Impact Microbe and Immune Cell Populations
Subclinical infections may alter the immune system and gut microbiota in the human host impacting how we respond to environmental stimuli like vaccines....
AUG 22, 2018
Immunology
AUG 22, 2018
Immune Response Runs on the Body Clock
Immune cell functions such as inflammation are dictated by your bodies circadian rhythm, responding daily to external stimuli on a 24 hour schedule....
SEP 07, 2018
Health & Medicine
SEP 07, 2018
What's Behind the Massive Measles Outbreak in Europe?
Measles is a disease that many believe was eradicated years ago. That's true, to a point, but like a bad penny, it's back. In the United States, th...
SEP 21, 2018
Immunology
SEP 21, 2018
Intrauterine Protection from Allergy Season
Pregnancies during allergy season may provide protection against allergy development in children...
Loading Comments...